
Erlonat 150 Mg Tablets, Natco Pharma Ltd
Contact Supplier
Strength 150 Mg
Packaging Size 1x30
Storage Store below 30 DegreeC
Shelf life 2 Years
Amravati
Verified Exporter4 yrs
★★★★★★★★★★
4.9(549)



Erlonat 150 mg tablets are primarily used to treat advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. As a tyrosine kinase inhibitor, it blocks the EGFR protein to slow or stop the growth of cancer cells. It is typically taken once daily on an empty stomach.






